Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03020966 · ClinicalTrials.gov registry record · Phase 4

IV vs. Oral Acetaminophen as a Component of Multimodal Analgesia After Total Hip Arthroplasty

A Phase 4 study of Pain, Postoperative and Opioid Use, sponsored by Hospital for Special Surgery, New York.

Completed
Registry status
Phase 4
Development phase
154
Enrollment target
1
Study location

NCT03020966: Completed Phase 4 study of Pain, Postoperative and Opioid Use, sponsored by Hospital for Special Surgery, New York.

NCT03020966 is a Phase 4 study of Pain, Postoperative and Opioid Use that has completed, run by Hospital for Special Surgery, New York. The registered enrollment target is 154 participants, below the 272-participant average among 113 other Pain, Postoperative trials with a reported enrollment target (43% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03020966, a Phase 4 study of Pain, Postoperative and Opioid Use, has completed, sponsored by Hospital for Special Surgery, New York.

COMPLETED
Registry status
Phase 4
Development phase
154 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine how well two different methods of administrating Tylenol reduce pain and improve patient satisfaction after total hip replacement (THR) surgery. The methods of administration are orally, via a pill that is to be swallowed, and intravenously. Our aim is to determine whether oral or intravenous administration of Tylenol will reduce opioid consumption and opioid-related side effects after THR.

Primary Outcome

Numerical rating scale of pain on a scale of 0-10, with 0 representing the minimum value of no pain and 10, representing the maximum, defined as being pain as bad as imaginable.

Interventions

  • DRUG Acetaminophen

Study Locations (1)

New York

  • Hospital for Special Surgery - New York

Trial Details

FieldValue
Enrollment Target 154 participants
Start Date 2017-02-16
Est. Completion 2019-06-16
Phase Phase 4

What the finished NCT03020966 record still lists

NCT03020966 is an interventional study that assigns participants to a tested intervention. The registered 154 participants enrollment target is mid-sized for trials with a published cap, below the 272-participant average among 113 other Pain, Postoperative trials with a reported enrollment target (43% lower).

The record links to 2 conditions, with Pain, Postoperative appearing as the primary indexed condition, and to 1 intervention - of which Acetaminophen is the first listed.

NCT03020966 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT03020966 about?

NCT03020966 is a clinical study titled "IV vs. Oral Acetaminophen as a Component of Multimodal Analgesia After Total Hip Arthroplasty". The purpose of this study is to determine how well two different methods of administrating Tylenol reduce pain and improve patient satisfaction after total hip replacement (THR) surgery. The methods of administration are orally, via a pill that is to be swallowed, and intravenously. Our aim is to de...

What is the current status of trial NCT03020966?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 154 participants. The study started on 2017-02-16. Estimated completion is 2019-06-16.

What conditions does trial NCT03020966 study?

This clinical trial studies the following conditions: Pain, Postoperative, Opioid Use.

What interventions are being tested in trial NCT03020966?

The interventions under investigation include: Acetaminophen (DRUG).

Who is sponsoring clinical trial NCT03020966?

This trial is sponsored by Hospital for Special Surgery, New York, which has 194 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03020966 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain, Postoperative

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03020966's enrollment target sits among peer trials

154 24th of 113 higher than 90 of 113 other Pain, Postoperative trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Pain, Postoperative trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04300998 · 154 participants

    Study of CAR-T Therapy in Older Patients

  • NCT04597372 · 154 participants · Phase 2

    Impact of Tamsulosin on Post-Operative Urinary Retention Following Pelvic Reconstructive Surgery

  • NCT05294042 · 154 participants · NA

    Patient Navigators for Children's Community Mental Health Services in High Poverty Urban Communities

  • NCT05512390 · 154 participants · Phase 1

    A Study to Assess the Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-319 Moves Through the Bodies of Adult Participants With Relapsed or Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL), or Chronic Lymphocytic Leukemia (CLL)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03020966, the US trial registry maintained by the National Library of Medicine. NCT03020966 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.